IP Verse

Use Of Cannabinoids In The Treatment Of Seizures Associated With Lennox-Gastaut Syndrome

Patent No. EP3710058 (titled "Use Of Cannabinoids In The Treatment Of Seizures Associated With Lennox-Gastaut Syndrome") was filed by GW Research on Nov 15, 2018. The application was issued on Oct 9, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
KRAUS & WEISERTJul 8, 2025KRAUS & LEDERER PARTGMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3710058

GW RESEARCH
Application Number
EP18808075A
Filing Date
Nov 15, 2018
Status
Granted And Under Opposition
Sep 6, 2024
Publication Date
Oct 9, 2024
External Links
Slate, Register , Google Patents